Augmented reality needle guidance for soft tissue biopsy
Part of Cancer, Digestive system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a new augmented reality system that helps guide the needle during a soft-tissue biopsy. It may make the procedure more accurate and easier for your doctor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You need a biopsy of a soft-tissue tumor (like in the breast, liver, or muscle) as part of your regular care.
- Your doctor has already said you can have a biopsy using ultrasound.
- Your tumor is at least 1 cm across and not deeper than 8 cm from the skin.
- Your BMI is 40 or less.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if augmented reality (a type of computer overlay) can help doctors perform MRI-guided needle procedures more accurately in children and young adults. It may lead to safer and more precise treatments.
This trial tests a robot-assisted method for taking prostate biopsies using a new type of ultrasound probe. It may help men with certain high-risk features get a more precise diagnosis.
This study tests a new augmented reality system to help doctors place needles in the liver during MRI scans for biopsies or ablation (heat to destroy tumors). The goal is to see if it improves accuracy and speed.
This trial tests an augmented reality (AR) tool to help surgeons locate breast cancer tumors during breast-conserving surgery. You may join if you have a single, small invasive breast tumor and have not had chemotherapy before surgery.
This study tests whether augmented reality—a technology that overlays digital images onto the surgeon's view—can help surgeons safely remove small liver tumors. You would receive standard surgery, but the surgeon would use AR guidance to locate and remove your tumor more precisely.
This study tests a new optical probe that takes special images during a needle biopsy to help guide doctors to collect better samples. It may help people with cancer in lymph nodes, liver, or lung who are already scheduled for an image-guided biopsy.
Hear when a new Oncology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.